XML 76 R59.htm IDEA: XBRL DOCUMENT v3.25.1
Restructuring and Exit Activity Costs (Tables)
 12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
The following table provides details regarding the net severance, termination benefit and other employee costs that were incurred (or reversed) under our 2023 Restructuring Plan and amounts that were settled with cash during the years ended December 31, 2024 and 2023, as well as the related accrued liability balances included in our consolidated balance sheets as of December 31, 2024 and 2023:

(in thousands)December 31, 2024December 31, 2023
Balance at beginning of period
$3,933 $— 
Costs incurred and other adjustments to accrued liability during the period
(30)8,242 
Amounts settled with cash
(3,416)(4,309)
Balance at the end of period
$487 $3,933 

The financial statement impacts of (1) severance, termination benefits and other employee costs that were incurred under our 2023 Restructuring Plan during the years ended December 31, 2024 and 2023 and (2) adjustments recorded with respect to the liability recognized under the 2023 Restructuring Plan during the year ended December 31, 2024 are reflected in our consolidated statements of operations as follows:

Year Ended
(in thousands)December 31, 2024December 31, 2023
Total cost of sales a
$(785)$1,401 
Selling, general and administrative
370 5,598 
Research and development
385 1,243 
Total
$(30)$8,242 
a.Only restructuring costs recorded to cost of sales have been included in our reported segment results, as gross profit is our measure of segment profitability. All severance and termination costs recorded to costs of sales are included in our Healthcare segment and, accordingly, are reflected in the Healthcare segment's reported gross profit. There were no facility termination costs or impairment costs included in the amounts reported for consolidated or segment cost of sales. See Note 21 for the reported gross profit for each of our reportable segments.